These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21713315)

  • 1. Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy.
    Chiu CA; Lu LF; Yu TH; Hung WC; Chung FM; Tsai IT; Yang CY; Hsu CC; Lu YC; Wang CP; Lee YJ
    Rev Diabet Stud; 2010; 7(4):275-84. PubMed ID: 21713315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Yeh LR; Chen HJ; Lee YJ; Houng JY
    Atherosclerosis; 2010 Aug; 211(2):579-83. PubMed ID: 20427046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.
    Wu IW; Hsu KH; Lee CC; Sun CY; Hsu HJ; Tsai CJ; Tzen CY; Wang YC; Lin CY; Wu MS
    Nephrol Dial Transplant; 2011 Mar; 26(3):938-47. PubMed ID: 20884620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
    Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
    Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of uremic toxins and inflammation in hemodialysis patients.
    Hsu HJ; Yen CH; Wu IW; Hsu KH; Chen CK; Sun CY; Chou CC; Chen CY; Tsai CJ; Wu MS; Lee CC
    PLoS One; 2014; 9(7):e102691. PubMed ID: 25051062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
    Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
    Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
    Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R
    Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients.
    Lu YC; Wu CC; Tsai IT; Hung WC; Lee TL; Hsuan CF; Yu TH; Wei CT; Chung FM; Lee YJ; Wang CP
    Clin Chim Acta; 2021 May; 516():83-91. PubMed ID: 33508250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events.
    Wang CP; Lu LF; Yu TH; Hung WC; Chiu CA; Chung FM; Hsu CC; Lu YC; Lee YJ; Houng JY
    J Nephrol; 2013; 26(1):111-8. PubMed ID: 22460182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
    Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
    Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic toxin development in living kidney donors: a longitudinal study.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
    Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method.
    Pretorius CJ; McWhinney BC; Sipinkoski B; Johnson LA; Rossi M; Campbell KL; Ungerer JP
    Clin Chim Acta; 2013 Apr; 419():122-6. PubMed ID: 23428591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bowel Habits and the Association With Uremic Toxins in Non-Dialysis-Dependent Chronic Kidney Disease Patients.
    Ramos CI; Armani RG; Canziani ME; Ribeiro Dolenga CJ; Nakao LS; Campbell KL; Cuppari L
    J Ren Nutr; 2020 Jan; 30(1):31-35. PubMed ID: 30956092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.
    Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
    Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
    PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate.
    Camacho O; Rosales MC; Shafi T; Fullman J; Plummer NS; Meyer TW; Sirich TL
    Nephrol Dial Transplant; 2016 Aug; 31(8):1335-41. PubMed ID: 27190347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.